Cargando…

A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study

BACKGROUND: Young people with sickle cell disease (SCD) often demonstrate low medication adherence and low motivation for effectively self-managing their condition. The growing sophistication of mobile phones and their popularity among young people render them a promising platform for increasing med...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Kristina, Lebedev, Anastasiya, Aguirre, Elisa, Lobitz, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604509/
https://www.ncbi.nlm.nih.gov/pubmed/31215518
http://dx.doi.org/10.2196/mhealth.8130
_version_ 1783431729660297216
author Curtis, Kristina
Lebedev, Anastasiya
Aguirre, Elisa
Lobitz, Stephan
author_facet Curtis, Kristina
Lebedev, Anastasiya
Aguirre, Elisa
Lobitz, Stephan
author_sort Curtis, Kristina
collection PubMed
description BACKGROUND: Young people with sickle cell disease (SCD) often demonstrate low medication adherence and low motivation for effectively self-managing their condition. The growing sophistication of mobile phones and their popularity among young people render them a promising platform for increasing medication adherence. However, so far, few apps targeting SCD have been developed from research with the target population and underpinned with theory and evidence. OBJECTIVE: The aim of this study was to develop a theory-and-evidence-based medication adherence app to support children and adolescents with SCD. METHODS: The Behavior Change Wheel (BCW), a theoretically based intervention development framework, along with a review of the literature, 10 interviews with children and adolescents with SCD aged between 12 and 18 years, and consultation with experts informed app development. Thematic analysis of interviews provided relevant theoretical and evidence-based components to underpin the design and development of the app. RESULTS: Findings suggested that some patients had lapses in memory for taking their medication (capability); variation in beliefs toward the effectiveness of medication and confidence in self-managing their condition (motivation); a limited time to take medication; and barriers and enablers within the changing context of social support during the transition into adulthood (opportunity). Steps were taken to select the appropriate behavioral change components (involving behavior change techniques [BCTs] such as information on antecedents, prompts/cues; self-monitoring of the behavior; and social support) and translate them into app features designed to overcome these barriers to medication adherence. CONCLUSIONS: Patients with SCD have complex barriers to medication adherence necessitating the need for comprehensive models of behavior change to analyze the problem. Children and adolescents require an app that goes beyond simple medication reminders and takes into account the patient’s beliefs, emotions, and environmental barriers to medication adherence.
format Online
Article
Text
id pubmed-6604509
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-66045092019-07-17 A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study Curtis, Kristina Lebedev, Anastasiya Aguirre, Elisa Lobitz, Stephan JMIR Mhealth Uhealth Original Paper BACKGROUND: Young people with sickle cell disease (SCD) often demonstrate low medication adherence and low motivation for effectively self-managing their condition. The growing sophistication of mobile phones and their popularity among young people render them a promising platform for increasing medication adherence. However, so far, few apps targeting SCD have been developed from research with the target population and underpinned with theory and evidence. OBJECTIVE: The aim of this study was to develop a theory-and-evidence-based medication adherence app to support children and adolescents with SCD. METHODS: The Behavior Change Wheel (BCW), a theoretically based intervention development framework, along with a review of the literature, 10 interviews with children and adolescents with SCD aged between 12 and 18 years, and consultation with experts informed app development. Thematic analysis of interviews provided relevant theoretical and evidence-based components to underpin the design and development of the app. RESULTS: Findings suggested that some patients had lapses in memory for taking their medication (capability); variation in beliefs toward the effectiveness of medication and confidence in self-managing their condition (motivation); a limited time to take medication; and barriers and enablers within the changing context of social support during the transition into adulthood (opportunity). Steps were taken to select the appropriate behavioral change components (involving behavior change techniques [BCTs] such as information on antecedents, prompts/cues; self-monitoring of the behavior; and social support) and translate them into app features designed to overcome these barriers to medication adherence. CONCLUSIONS: Patients with SCD have complex barriers to medication adherence necessitating the need for comprehensive models of behavior change to analyze the problem. Children and adolescents require an app that goes beyond simple medication reminders and takes into account the patient’s beliefs, emotions, and environmental barriers to medication adherence. JMIR Publications 2019-06-18 /pmc/articles/PMC6604509/ /pubmed/31215518 http://dx.doi.org/10.2196/mhealth.8130 Text en ©Kristina Curtis, Anastasiya Lebedev, Elisa Aguirre, Stephan Lobitz. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 18.06.2019. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/.as well as this copyright and license information must be included.
spellingShingle Original Paper
Curtis, Kristina
Lebedev, Anastasiya
Aguirre, Elisa
Lobitz, Stephan
A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
title A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
title_full A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
title_fullStr A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
title_full_unstemmed A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
title_short A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
title_sort medication adherence app for children with sickle cell disease: qualitative study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604509/
https://www.ncbi.nlm.nih.gov/pubmed/31215518
http://dx.doi.org/10.2196/mhealth.8130
work_keys_str_mv AT curtiskristina amedicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT lebedevanastasiya amedicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT aguirreelisa amedicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT lobitzstephan amedicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT curtiskristina medicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT lebedevanastasiya medicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT aguirreelisa medicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy
AT lobitzstephan medicationadherenceappforchildrenwithsicklecelldiseasequalitativestudy